Literature DB >> 27497332

An autopsy case of acetyl fentanyl intoxication caused by insufflation of 'designer drugs'.

Izumi Takase1, Takako Koizumi2, Ihoko Fujimoto3, Aya Yanai3, Tatsuya Fujimiya3.   

Abstract

We present a fatal case of intoxication due to insufflation of acetyl fentanyl. His blood concentration of acetyl fentanyl was 270ng/mL, and the manner of death was classified as an accident. This is the first report of an autopsy case of acetyl fentanyl delivered by insufflation, rather than intravenous administration. He had been snoring loudly for at least 12h prior to death, and transport to a hospital during this time and treatment with naloxone may have saved his life. In this sense, it can be said that his death was preventable. This case reemphasizes the risk of death associated with drug overdose and the narrow range of acetyl fentanyl between the effective dose (ED50) and lethal dose (LD50). The case should also raise awareness among medical professionals of the effectiveness of naloxone and the need to establish a comprehensive system for toxicological analysis while keeping the possibility of use of 'designer drugs' in mind.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Acetyl fentanyl; Designer drugs; Insufflation; Naloxone

Mesh:

Substances:

Year:  2016        PMID: 27497332     DOI: 10.1016/j.legalmed.2016.05.006

Source DB:  PubMed          Journal:  Leg Med (Tokyo)        ISSN: 1344-6223            Impact factor:   1.376


  10 in total

1.  A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose.

Authors:  Matthew K Griswold; Peter R Chai; Alex J Krotulski; Melissa Friscia; Brittany P Chapman; Neha Varma; Edward W Boyer; Barry K Logan; Kavita M Babu
Journal:  J Med Toxicol       Date:  2017-10-02

2.  Identification and quantification of mepirapim and acetyl fentanyl in authentic human whole blood and urine samples by GC-MS/MS and LC-MS/MS.

Authors:  Akira Mochizuki; Hiroko Nakazawa; Noboru Adachi; Kenichi Takekawa; Hideki Shojo
Journal:  Forensic Toxicol       Date:  2017-09-12       Impact factor: 4.096

Review 3.  An Expanding World of Novel Psychoactive Substances: Opioids.

Authors:  Jolanta B Zawilska
Journal:  Front Psychiatry       Date:  2017-06-30       Impact factor: 4.157

Review 4.  Postmortem Toxicology of New Synthetic Opioids.

Authors:  Marta Concheiro; Rachel Chesser; Justine Pardi; Gail Cooper
Journal:  Front Pharmacol       Date:  2018-10-26       Impact factor: 5.810

Review 5.  Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.

Authors:  Barbara Lovrecic; Mercedes Lovrecic; Branko Gabrovec; Marco Carli; Matteo Pacini; Angelo G I Maremmani; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-01-09       Impact factor: 3.390

6.  Postmortem distribution of mepirapim and acetyl fentanyl in biological fluid and solid tissue specimens measured by the standard addition method.

Authors:  Akira Mochizuki; Hiroko Nakazawa; Noboru Adachi; Kenichi Takekawa; Hideki Shojo
Journal:  Forensic Toxicol       Date:  2018-07-07       Impact factor: 4.096

Review 7.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

Review 8.  Drug Interactions With New Synthetic Opioids.

Authors:  Clara Pérez-Mañá; Esther Papaseit; Francina Fonseca; Adriana Farré; Marta Torrens; Magi Farré
Journal:  Front Pharmacol       Date:  2018-10-11       Impact factor: 5.810

Review 9.  Novel Synthetic Opioids: The Pathologist's Point of View.

Authors:  Paolo Frisoni; Erica Bacchio; Sabrine Bilel; Anna Talarico; Rosa Maria Gaudio; Mario Barbieri; Margherita Neri; Matteo Marti
Journal:  Brain Sci       Date:  2018-09-02

Review 10.  The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.

Authors:  Ying Han; Wei Yan; Yongbo Zheng; Muhammad Zahid Khan; Kai Yuan; Lin Lu
Journal:  Transl Psychiatry       Date:  2019-11-11       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.